To explore the roles of EGFR and IL-6-STAT3 in ovarian cancer, we first comprehensively explored the prognostic significance of EGFR and IL-6-STAT3 pathway in patients with ovarian carcinoma using the Kaplan–Meier plotter (KM plotter). This evidence concerns the gene IL6 and ovarian cancer.